Features Partner Sites Information LinkXpress
Sign In

MR Elastography Detects Pediatric Liver Disease Without Need for Needle Biopsy

By Medimaging International staff writers
Posted on 03 Oct 2013
Print article
Magnetic resonance elastography (MRE), noninvasive imaging technique, can now help physicians effectively identify fibrosis in children with chronic liver disease, a growing problem caused partly by the increase of obesity rates.

The new study revealed that MRE detects such chronic diseases as nonalcoholic fatty liver disease (NAFLD), which is increasingly common in children and teens, affecting an estimated 13% of adolescents. NAFLD can lead to progressive liver disease and liver failure. Obesity is a major risk factor. “Because many pediatrics patients in the United States with NAFLD are severely obese, MRE is likely to be superior to ultrasound-based elastography in this population, as ultrasound-based methods are less reliable in severely obese patients,” stated Stavra Xanthakos, MD, a gastroenterologist at Cincinnati Children’s Hospital Medical Center (OH, USA), and lead author of the study.

The study was published online September 23, 2013, in the Journal of Pediatrics. If the findings are confirmed in larger studies, MRE could lessen dependence on expensive and invasive liver biopsies to detect fibrosis. The researchers, in 2011 and 2012, evaluated 35 children and teenagers between the ages of 4 and 20 for chronic liver disease employing both liver biopsy and MRE. The study demonstrated that MRE was highly accurate in detecting more advanced fibrosis in children with chronic liver disease, including severely obese patients.

A needle biopsy is standard practice for assessing liver fibrosis. This not only has risks for the patient and high expense, but it is frequently quite scary for children and teens. MRE is a way to gauges tissue stiffness that uses low frequency sound waves in combination with magnetic resonance, which involves the combination of magnetic fields and radio frequency waves to generate diagnostic images. MRE can be accomplished in just a few minutes using the MR scanner.

“Having the ability to easily and noninvasively assess the degree of fibrosis in a child's liver could help us identify the issue early and being the right course of treatment in a timely and effective manner,” noted Daniel Podberesky, MD, chief of thoracoabdominal imaging at Cincinnati Children's and a coauthor of the study. “An added strength of magnetic resonance technology is the ability to more precisely measure liver fat, which allows us to noninvasively determine changes in liver fat quantity after clinical interventions.”

“Our results show the exciting potential of MRE to improve clinical care and reduce dependence on liver biopsies, but it is not yet ready for primetime clinical use,” added Dr. Xanthakos. “In addition to validation in larger pediatric cohorts, we still need to determine whether MRE can predict changes in liver disease over time. We hope to study MRE in patients to test how well changes in imaging correlate with changes in liver stiffness after treatment or lifestyle changes.”

Dr. Xanthakos codirects the Cincinnati Children’s Steatohepatitis Center. Steatohepatitis is an advanced stage of fatty liver disease. In all, physicians at Cincinnati Children’s have effectively evaluated more than 200 children using liver MRE with no adverse events.

Related Links:

Cincinnati Children’s Hospital Medical Center

Print article



view channel
Image: New Scenaria SE 64/128-slice Computed Tomography Scanner from Hitachi Medical Systems America (Photo courtesy of Business Wire).

Two new 64/128-Slice CT Scanners Cleared by the FDA

A major diagnostic imaging equipment provider has announced US FDA clearance of two new 64/128-slice Computed Tomography (CT) scanners. The Food and Drug Administration (FDA; Silver Spring, MD, USA)... Read more


view channel

Fast, Noninvasive Assessment of Chronic Liver Disease Announced as Alternative to Biopsies

A leading ultrasound imaging vendor has presented the clinical benefits of its innovative technology for noninvasive assessment of the severity of liver fibrosis, at the Liver Meeting 2015, in San Francisco (CA, USA). Researchers have published more than 60 items on the reliability and effectiveness of the new technology.... Read more

Nuclear medicine

view channel
Image: Glioblastoma in a PET scanner with (left) and without (right) the YY146 marker (Photo courtesy of Weibo Cai, WISC).

Antibody Cancer Marker Causes Tumors to Light Up

A novel marker attaches to a molecule on highly aggressive brain cancer, resulting in glioblastoma tumor tissue being easily identified in a positron emission tomography (PET) scanner. Developed by... Read more

Imaging IT

view channel
Image: CTA images displayed in Google Glass (Photo courtesy of the Canadian Journal of Cardiology).

Virtual Reality Device Helps Treat Blocked Arteries

A wearable virtual reality (VR) device based on Google Glass can be used to guide revascularization of chronically blocked coronary arteries. Developed by researchers at the Institute of Cardiology... Read more

Industry News

view channel

Long-Term Strategic Managed Medical Equipment Services Partnership Announced

An 18-year strategic collaboration agreement, worth CAD 300 million, between a major medical imaging vendor and the Southwest York Region of Ontario in Canada, has been announced. The partnership is for managed equipment services to help advance medical technology in the Southwest York region, and to expand the accessibility... Read more
Copyright © 2000-2015 Globetech Media. All rights reserved.